Science & Innovation 03.17.2023
For the first time ever, Amgen convened the cardiovascular disease community to align around a singular mission to help patients manage LDL-C.
Patients 03.13.2023
Responsibility 03.08.2023
Patients 03.02.2023
Patients 03.01.2023
Science & Innovation 02.27.2023
Amgen’s research site in Burnaby, British Columbia, Canada, is working to build human immune system models that can help predict immune reactions to medicines in development.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
